A randomized trial of Trendelenburg position for acute moderate ischemic stroke.
Hui-Sheng Chen, Nan-Nan Zhang, Yu Cui...
https://pubmed.ncbi.nlm.nih.gov/37147320/Actively Recruiting
Led by University of Milano Bicocca · Updated on 2026-05-06
118
Participants Needed
6
Research Sites
13 weeks
Total Duration
Researchers are investigating the use of head down tilt at -10 to -15 HDT15 as a possible therapy to improve collateral blood flow in adults with acute ischemic stroke caused by a blockage in the middle cerebral artery MCA. This multicenter, randomized, controlled, open-label trial with blinded outcome assessment aims to compare HDT15 positioning with the usual positioning 0 to 30 before mechanical thrombectomy, a procedure to remove the blockage. The study seeks to determine if HDT15 can enhance collateral circulation, extend the survival of brain tissue at risk, and improve outcomes from thrombectomy. The intervention group will have their head tilted downward by 10 to 15 starting in the Emergency Room and maintained during transfer to and throughout the mechanical thrombectomy procedure, using specialized equipment to ensure precise angles. The control group will receive standard care with usual positioning between 0 to 30. The HDT15 therapy is expected to last approximately 30 to 90 minutes, covering the critical period before and during thrombectomy. Participants will be closely monitored during the study for neurological changes, blood pressure, oxygen levels, and any side effects such as vomiting or pneumonia. Imaging assessments will be performed during thrombectomy to evaluate collateral blood flow. Functional outcomes will be measured up to three months after treatment. The study includes safety monitoring to track any complications and ensure patient well-being throughout the trial, which runs through the end of 2026.
CONDITIONS
Head Down Tilt 15° to Increase Collateral Flow in Acute Ischemic Stroke
S
Simone Beretta, MD, PhD
B
BiCRO (academic CRO)
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Milano Bicocca
Lead Sponsor
Fondazione IRCCS San Gerardo dei Tintori
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 30 to 90 minutes
Participants who are eligible will receive head down tilt positioning at -10° to -15° during the emergency room phase and mechanical thrombectomy procedure to improve collateral blood flow in acute ischemic stroke. The positioning will be maintained during transfer and the thrombectomy procedure.
1 continuous treatment session during emergency room and angiography suite care
Duration - 3 months
Participants will be monitored for neurological status, complications, and clinical outcomes after treatment including assessments at 1 day and 3 months post-procedure.
Follow-up visits at 1 day and 3 months post-treatment
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Hui-Sheng Chen, Nan-Nan Zhang, Yu Cui...
https://pubmed.ncbi.nlm.nih.gov/37147320/Susanna Diamanti, Jacopo Mariani, Alessandro Versace...
https://pubmed.ncbi.nlm.nih.gov/36300727/Simone Beretta, Alessandro Versace, Davide Carone...
https://pubmed.ncbi.nlm.nih.gov/28112023/Francesco Andrea Pedrazzini, Lorenzo Piergallini, Susanna Diamanti...
https://pubmed.ncbi.nlm.nih.gov/41815317/Alexandre Gauthier, Patrick Gérardin, Pauline Renou...
https://pubmed.ncbi.nlm.nih.gov/30056454/Craig S Anderson, Hisatomi Arima, Pablo Lavados...
https://pubmed.ncbi.nlm.nih.gov/28636854/University of Milano Bicocca
Lead Sponsor
Fondazione IRCCS San Gerardo dei Tintori
Collaborating Sponsor